The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...

Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...

A caregivers empowerment workshop will be held at the Frugal Bookstore in Roxbury on Friday evening, as part of National ...

Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.

When Ellie Wilcock was hit by sharp pains in her abdomen and sudden bouts of fatigue in 2022, she blamed it on a urinary ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is taking part in the Fourth International Congress of the Asian Oncology Society and the ...

Clemson University's first African American woman to become a tenured professor at Clemson University's College of Education ...

Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following ...

LEANNE Battersby looks set to be left rattled in the coming days on Coronation Street. Over the past few months, fans of the ...